AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$BTI

JPMorgan Names Dividend Giant Its Top Stock Pick for a Rocky Market

JPMorgan (JPM) initiated coverage of British American Tobacco (BTI) with an Overweight rating and a 53 price target, citing resilient cash flows, smokeless nicotine growth, and shareholder returns. The bank expects 3-5% revenue growth in 2027 and highlights BTI's defensive characteristics. BTI reported 18% revenue growth in New Categories for H1 2026 and aims for 5-8% EPS growth in 2026.

Original reporting
finance.yahoo.com
Published Nov 10, 2026, 7:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 7:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
JPMorgan Names Dividend Giant Its Top Stock Pick for a Rocky Market — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$BTIBullishMed
01

Why it matters

The upgrade provides a clear catalyst for price appreciation, especially for income‑focused investors.

02

Market read

Analyst upgrade on a major dividend stock offers a timely trade idea in a volatile market.

03

What to watch

Potential impact of stricter global nicotine regulations and competition from illicit vaping markets.

Relevance 7/10Novelty 7/10Timing: today

Background

JPMorgan's analyst team issued a fresh Overweight rating on BTI, citing resilient cash flows and growth in new nicotine categories.

Company-level read

Ticker impact

$BTIBullishHigh confidence
Context

JPMorgan reinstated coverage on British American Tobacco with an Overweight rating and a $53 price target, highlighting its defensive cash flow and growth in smokeless products.

Expected impact

potential upside as the market prices in the new target and overweight rating

Evidence & confidence

The rating change is a fresh, primary disclosure with a concrete price target, offering a clear actionable catalyst.

Market effects

Sector

Highlights the defensive appeal of the tobacco sector amid market volatility, possibly lifting peer valuations.

Regional

Emphasizes growth in U.S. smokeless nicotine products, which could benefit other U.S. nicotine‑related firms.

Global

Reinforces dividend‑yield strategies globally as investors seek stable cash‑flow stocks.

Counterpoint

What could challenge this read

The regulatory risk around nicotine products and declining cigarette volumes could outweigh the upside from the upgrade.

Key entities

  • company
    British American Tobacco

    Global tobacco company with expanding smokeless nicotine portfolio.

  • financial_institution
    JPMorgan

    Issuer of the new rating and price target.

Read at source← All news

StoryJPMorgan reinstates coverage of British American Tobacco with Overweight rating and GBP 53 price target

Related articles

$BTIMed

JPMorgan reinstates British American Tobacco stock coverage with overweight rating

JPMorgan reinstated coverage on British American Tobacco (BTI) with an overweight rating and a GBP53.00 price target. The firm cited strong growth prospects and attractive valuation, expecting 3-5% like-for-like growth in 2027. Goldman Sachs also upgraded BTI to Buy, noting a clear growth inflection story. The stock trades at a P/E ratio of 15.4 and offers a 5.5% dividend yield.

investing.com
$BTIHigh

Goldman upgrades BAT on clearer path to sustained revenue growth

Goldman Sachs upgraded British American Tobacco (BAT) to 'buy' from 'neutral', raising its price target to 5,600 pence. The firm expects 4% organic sales growth in 2027-2028, driven by resilient combustible sales and New Categories growth. BAT trades at 12 times expected 2027 earnings, with a dividend yield near 6%. Goldman forecasts 5%-6% medium-term operating profit growth and 9% average EPS growth over five years, citing Velo Max and Vuse vapour volume growth as key drivers.

investing.com
$BTIMed

VELO Nicotine Pouches Receive U.S. FDA Marketing Authorization

Reynolds American Inc. received FDA marketing authorization for select VELO nicotine pouches, including various flavors and strengths. The company plans to invest $3.2 billion in smokeless products, aiming to reduce cigarette use and create jobs. According to the CEO, FDA-approved alternatives support declining smoking rates.

prnewswire.com